Invested
in Her
A Space For Dialogue, Connection, and Action
Women live longer than men on average, yet spend significantly more of those years in declining health. The gap between lifespan and healthspan for women is one of the most consequential yet underfunded problems in healthcare and research. The LSF is bringing together a room of people who understand the stakes and want a part of their legacy to be changing this reality.
The Invested in Her event is a curated gathering for investors, advocates, clinicians, philanthropists, and people who recognize the urgency of investing in women's health. The goal is creating connections with purpose: real conversations, practical takeaways, and relationships that will extend beyond the room. Proceeds and generous donations support our $250,000 campaign to fund critical research combating key drivers of cardiometabolic, neurodegenerative, and skeletal disease risk in women that are known, but severely understudied and under-resourced: ovarian aging and menopause.
Key Features
You will hear from a diverse cast of speakers — both inside and outside of healthcare. From courageous women sharing their health journeys and stories, to Venture Capital leaders at the forefront of commercial investment in women's health, to industry experts responsible for shaping the future. These conversations are real, impactful, and paint the picture of what we need to be better Invested in Her. Learn about the massive evidence gap in women's health science, where targeted research funding can catalyze impact, and hear the realities of what not investing in women for decades has done.
Presentations from a first-of-its-kind leading women's health company and the Longevity Science Foundation, discussing the importance of supporting research via Invested in Her.
Dedicated time to connect with attendees, speakers, and sponsors, all of whom are Invested in Her. Build real connections to last, and teams to drive action. The room is meant to be diverse, to escape the echo chamber and drive multi-stakeholder engagement. Come with an open mind, leave with powerful allies.
Speakers
Sarah Mouser is the Executive Vice President of Financial Planning for Merit Financial Advisors. A strategic leader with more than 20 years of experience, she drives the firm's financial planning platform, enhancing planning infrastructure, scalability, operational efficiency, and the overall client experience. As a member of the firm's strategic leadership team, she spearheads platform development and process improvement efforts designed to support consistent, high-quality planning across the organization. Sarah also serves on the Financial Planning and Wealth Management Advisory Boards for Virginia Tech and George Mason University, where she invests her time and expertise in supporting the future of the profession.
LinkedIn Marie Fisher has more than 25 years of experience leading the commercialization of biopharmaceutical and medical device products across multiple therapeutic areas, including respiratory, diabetes, and infectious disease. Through her work with healthcare professionals, patients, and payers, she has seen firsthand how improving access to care, delivering tailored education, and demonstrating evidence-based outcomes can strengthen pivotal moments in a woman's health journey. Marie brings both professional expertise and personal perspective to her work, drawing on her experiences as a caregiver and hospice volunteer. She believes that optimizing women's longevity requires moving beyond transaction-based healthcare to relationship-centered engagement that supports better outcomes throughout every stage of life.
LinkedIn Lindsey Seal is a partnerships and capital markets professional with twenty years of experience driving revenue and scaling operations in advertising, tech startups, and private equity. A Birmingham native and Auburn University graduate, she has been successful because of her curious nature, willingness to learn, and focus on developing strong relationships. She can be found bandaging paper cuts and putting out fires, while refining processes to make sure missteps do not happen twice.
She currently serves as Director of Capital Markets at Revitalization Unlimited, where she leads investor engagement and partnerships for their tax-advantaged investments in historic real estate and legacy businesses. She is passionate about advancing women in leadership, career development, and genuine connections. In her time away from work, she stays active through boxing workouts and chauffeuring her two boys to baseball, lacrosse, band, and football. Lindsey finds joy in live music, great wine, and time by the water.
LinkedIn Nim Singh Dua, MPH, is a public health and healthcare executive with more than twenty years of leadership experience across the academic, nonprofit, and corporate healthcare sectors. She currently serves as Executive Director of the Empire State ALS Alliance, Chair of the Board of Directors at the American Migraine Foundation, board member of the American Headache Society, Advisory Board member of the International Concussion Society, and appointed member of the NY State Rare Disease Advisory Council. Previously, she served as Executive Director of both the American Migraine Foundation and the International Headache Society Global Patient Advocacy Coalition, leading global patient advocacy and cross-sector collaboration in headache medicine, a field in which women are disproportionately affected and historically underserved. Her career has included senior executive, research, and strategy roles at Atria Health, the National Kidney Foundation, the New York State Health Foundation, the Young Survival Coalition, and Nassau University Medical Center, spanning disease areas including migraine, ALS, HIV/AIDS, diabetes, cardiovascular disease, kidney disease, and breast cancer. A published contributor in headache and migraine medicine, she has collaborated with global and federal stakeholders including the World Health Organization, the CDC, and the FDA. Nim holds a Bachelor's degree in Human Services and Health Sciences from Northeastern University and a Master of Public Health in Community Health from Hofstra University.
LinkedIn Deanna Angello is the Founder and President of Alpenglow Ventures, a strategic advisory firm helping life sciences and health tech companies translate innovation into adoption, access, and growth. A C-suite commercial and business executive with more than 25 years of experience across Fortune 50 healthcare companies and clinical-stage biotechnology, she is a commercialization expert known for guiding teams through market creation, enterprise growth, and transformational change. Deanna has held senior leadership roles at Pfizer, Genentech/Roche, Kite/Gilead, Johnson & Johnson, and Cognito Therapeutics, where she led teams and strategies that built markets, scaled brands, and expanded patient access across seven $1B medicines. She is an investor in Portfolia's Active Aging and Longevity Fund and advises founders across the U.S. on health innovation, with particular depth in brain health, longevity, and women's health, helping translate innovative science and technology into adoption, access, and meaningful patient impact.
LinkedInAgenda
Agenda is subject to change.
Companies Present
Alongside researchers, clinicians, and investors, Invested in Her will welcome leading companies working directly in women's health. Their presence makes these conversations more grounded, more applied, and more connected to the real pipeline of solutions being built today.
Register & Support the Cause
This event emphasizes the quality of its attendees, participants, and interactions over quantity to foster action, innovation, and high-profile engagement. Attendance is limited to 85 seats.
Donations raised support mission-driven women's health research: our Invested in Her campaign has identified 6 projects that will meaningfully move the needle in preventing numerous poor health outcomes and premature mortality in women, as champions of female longevity. All donations to the LSF are tax-deductible. As a registered 501(c)(3) organization, we ensure you receive a charitable gift receipt promptly.
Every dollar raised goes directly to early-stage research on women's health and longevity, with no overhead deducted. If you can't be in the room, your support still moves the science forward.
Sponsors
Tell Us Who You Want to Meet
If there are particular types of researchers, investors, clinicians, or operators it would be valuable for you to connect with, let us know and we'll do our best to make the right introduction at the event.
Share Your Networking Goals Oriana Papin-Zoghbi is the CEO and co-founder of AOA Dx and a visionary leader in women's health innovation and diagnostics. Under her leadership, AOA Dx has raised over $30 million to advance a first-in-class diagnostic platform aimed at transforming ovarian cancer detection. She has built and scaled a high-performing, mission-driven team, guiding the company through product and clinical development, regulatory strategy, and rapid organizational growth.
Recognized in Inc.'s Top 100 Female Founders for her groundbreaking work in ovarian cancer diagnostics, Oriana is a strong advocate for closing critical gaps in women's health. She brings deep global experience launching and commercializing diagnostics — from HPV screening programs in East Africa to innovations in oncology, maternal-fetal medicine, and infectious diseases. Oriana holds a degree in Economics and International Relations from Boston University and brings a global, equity-focused perspective to advancing women's health worldwide.
LinkedIn Patricia is the founder and president of the Silverstein Dream Foundation, a nonprofit dedicated to funding cutting-edge medical research for the Diabetes Research Institute and promoting early detection programs for prediabetes, type 1, and type 2 diabetes. She is passionate about holistic approaches, incorporating nutrition, diet management, and meditation techniques to improve glucose levels and insulin resistance.
Her efforts have earned her prestigious awards and recognitions, including:
- First female honoree at the Empire Ball Gala (2022), hosted by the Diabetes Research Institute Foundation, where she received the Leadership Award.
- The Leadership and Visionary Health Award from the Dominican Women Development Center (DWDC) for her Diabetes Prevention Program, aimed at reducing diabetes rates in underrepresented communities.
Patricia also serves on the Board of The Cure Alliance, a nonprofit dedicated to funding emergency treatments for pancreatic cancer and diabetes-related complications. Her mission is clear: to find a cure for diabetes and empower individuals to overcome health challenges by leveraging all available resources.
LinkedIn Bio coming soon.
LinkedIn Joshua C. Herring is the President & CEO of the Longevity Science Foundation (LSF), a 501(c)(3) nonprofit funding research to expand the healthy human lifespan. Prior to joining the LSF, Josh held years of experience in ultra-high net worth private wealth management at Alliance Bernstein, where he built an impressive track record delivering customized wealth planning, investment strategies, and innovative goal-oriented solutions. He managed a team of four, overseeing more than $2 billion in assets for a diverse clientele including individuals and institutional organizations domestically and internationally.
As President & CEO of the LSF, Josh focuses on strategic business growth and is dedicated to enhancing fundraising and grant-making efforts to fund new, innovative, life-saving research via individual and corporate partnerships. Since his arrival, the LSF has begun funding three new research projects at the University of Oxford, Stanford University, and the University of Copenhagen. He also launched the LSF Education bank, consisting of evidence-backed, digestible longevity education content to give readers agency in their health journeys. He has been featured in Forbes, is a Marquis Who's Who 2025 awardee, and speaks frequently on panels surrounding the intersection of healthcare and philanthropy across the globe.
LinkedIn Casey Albert has 20+ years of global operating experience building, scaling and investing in women's health companies. Casey is a Managing Partner at SteelSky Ventures, a female-led venture capital fund investing in early-stage companies that improve access, care, and outcomes in women's health. Prior to joining SteelSky, Casey invested in early-stage digital health & consumer health start-ups in partnership with Johnson & Johnson. She was CEO/Founder of Kangu, a maternal health tech platform that was acquired in 2018, and was an early product leader at Kiva, which has facilitated billions of dollars in microloans to female entrepreneurs in the US and globally.
Casey serves as an advisor to a number of venture-backed women's health start-ups and speaks frequently on entrepreneurship and women's health. She holds a BA from Wellesley College and an MBA from Columbia Business School.
LinkedIn